Literature DB >> 12399968

Dynamics of hematopoiesis in paroxysmal nocturnal hemoglobinuria (PNH): no evidence for intrinsic growth advantage of PNH clones.

D J Araten1, M Bessler, S McKenzie, H Castro-Malaspina, B H Childs, F Boulad, A Karadimitris, R Notaro, L Luzzatto.   

Abstract

PNH is characterized by expansion of one or more stem cell clones with a PIG-A mutation, which causes a severe deficiency in the expression of glycosylphosphatidylinositol (GPI)-anchored proteins. There is evidence that the expansion of PIG-A mutant clones is concomitant with negative selection against PIG-A wild-type stem cells by an aplastic marrow environment. We studied 36 patients longitudinally by serial flow cytometry, and we determined the proportion of PNH red cells and granulocytes over a period of 1-6 years. We observed expansion of the PNH blood cell population(s) (at a rate of over 5% per year) in 12 out of 36 patients; in all other patients the PNH cell population either regressed or remained stable. The dynamics of the PNH cell population could not be predicted by clinical or hematologic parameters at presentation. These data indicate that in most cases the PNH cell expansion has already run its course by the time of diagnosis. In addition, since in most cases no further expansion takes place, we can infer that the tendency to overgrow normal cells is not an intrinsic property of the PNH clone.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12399968     DOI: 10.1038/sj.leu.2402694

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  17 in total

Review 1.  Pathogenesis of selective expansion of PNH clones.

Authors:  Hideki Nakakuma; Tatsuya Kawaguchi
Journal:  Int J Hematol       Date:  2003-02       Impact factor: 2.490

2.  The clinical relevance of minor paroxysmal nocturnal hemoglobinuria clones in refractory cytopenia of childhood: a prospective study by EWOG-MDS.

Authors:  A M Aalbers; V H J van der Velden; A Yoshimi; A Fischer; P Noellke; C M Zwaan; I Baumann; H B Beverloo; M Dworzak; H Hasle; F Locatelli; B De Moerloose; G Göhring; M Schmugge; J Stary; M Zecca; A W Langerak; J J M van Dongen; R Pieters; C M Niemeyer; M M van den Heuvel-Eibrink
Journal:  Leukemia       Date:  2013-06-28       Impact factor: 11.528

3.  CRISPR/Cas9 PIG -A gene editing in nonhuman primate model demonstrates no intrinsic clonal expansion of PNH HSPCs.

Authors:  Tae-Hoon Shin; Eun Jung Baek; Marcus A F Corat; Shirley Chen; Jean-Yves Metais; Aisha A AlJanahi; Yifan Zhou; Robert E Donahue; Kyung-Rok Yu; Cynthia E Dunbar
Journal:  Blood       Date:  2019-04-19       Impact factor: 22.113

4.  The rate of spontaneous mutations in human myeloid cells.

Authors:  David J Araten; Ondrej Krejci; Kimberly Ditata; Mark Wunderlich; Katie J Sanders; Leah Zamechek; James C Mulloy
Journal:  Mutat Res       Date:  2013-06-06       Impact factor: 2.433

Review 5.  Recent advances in biological and clinical aspects of paroxysmal nocturnal hemoglobinuria.

Authors:  Lucio Luzzatto; Giacomo Gianfaldoni
Journal:  Int J Hematol       Date:  2006-08       Impact factor: 2.490

Review 6.  Expanding Complement Therapeutics for the Treatment of Paroxysmal Nocturnal Hemoglobinuria.

Authors:  Dimitrios C Mastellos; Edimara S Reis; Despina Yancopoulou; Antonio M Risitano; John D Lambris
Journal:  Semin Hematol       Date:  2018-02-14       Impact factor: 3.851

7.  Paroxysmal nocturnal hemoglobinuria: pathophysiology, natural history and treatment options in the era of biological agents.

Authors:  Antonio M Risitano; Bruno Rotoli
Journal:  Biologics       Date:  2008-06

8.  The mutation rate in PIG-A is normal in patients with paroxysmal nocturnal hemoglobinuria (PNH).

Authors:  David J Araten; Lucio Luzzatto
Journal:  Blood       Date:  2006-03-16       Impact factor: 22.113

Review 9.  Complement in paroxysmal nocturnal hemoglobinuria: exploiting our current knowledge to improve the treatment landscape.

Authors:  Dimitrios C Mastellos; Daniel Ricklin; Despina Yancopoulou; Antonio Risitano; John D Lambris
Journal:  Expert Rev Hematol       Date:  2014-09-02       Impact factor: 2.929

10.  A quantitative analysis of genomic instability in lymphoid and plasma cell neoplasms based on the PIG-A gene.

Authors:  David J Araten; Jose A Martinez-Climent; Mary Ann Perle; Eliana Holm; Leah Zamechek; Kimberly DiTata; Katie J Sanders
Journal:  Mutat Res       Date:  2010-01-08       Impact factor: 2.433

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.